Drugs / Bacteriostatic Normal Saline
Bacteriostatic Normal Saline
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04495868 | Jan 2021 → Apr 2022 | chronic pain syndrome | Emory University | Completed | No outcome recorded |
| Phase 4 | NCT01759459 | Jan → Jun 2013 | — | Allina Health System | Completed | Met primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bacteriostatic Normal Saline | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01759459 ↗ |
| Known as | BNS | “A skin wheal will be made with bacteriostatic normal saline (BNS).” NCT04495868 ↗ |
| Known as | Hospira brand Bacteriostatic Normal Saline in 10 mL vial | “Hospira brand Bacteriostatic Normal Saline in 10 mL vial” NCT01759459 ↗ |
| Route | Other | “administered one time intradermally in peripheral forearm” NCT01759459 ↗ |